On January 7, 2021 Cyteir Therapeutics, a leader in the discovery and development of next-generation synthetic lethal therapies to treat cancer, reported that Markus Renschler, M.D., Cyteir’s president and chief executive officer, will present a scientific and business update at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021 at 5:30 p.m. Eastern Time (Press release, Cyteir Therapeutics, JAN 7, 2021, View Source [SID1234577662]). A Q&A breakout session will immediately follow the presentation at 5:45 p.m. Eastern Time.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!